Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.11 | N/A |
| PEG Ratio (TTM) | -0.19 | N/A |
| P/S Ratio (TTM) | 0.72 | N/A |
| P/B Ratio (TTM) | 1.67 | N/A |
| P/FCF Ratio (TTM) | 12.41 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.97 | N/A |
| Price to 5YR AVG FCF Ratio | 19.21 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.79% | N/A |
| ROE (TTM) | 22.54% | N/A |
| Net Profit Margin (TTM) | 12.29% | N/A |
| ROIC 5YR AVG | 12.77% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 40.58% | 4.71% | 49.72% |
| Revenue | -1.26% | 3.33% | 7.33% |
| Net Income | 37.16% | 6.62% | 53.07% |
| Cash Flow | 15.97% | -8.92% | 5.34% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.50 | N/A |
| Quick Ratio (TTM) | 1.06 | N/A |
| D/E Ratio (TTM) | 1.07 | N/A |
| Interest Coverage (TTM) | 5.75 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.16 | N/A |
| LTL to 5YR AVG FCF | 9.02 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.95% | N/A |